Skip to main content
logo
Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
202.20
+3.68 (1.85%)
Sep 1, 2026, 10:14 AM EDT - Market open

Axsome Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
10,5919,2074,1003,7663,3491,424
Market Cap Growth
74.17%124.55%8.88%12.44%135.22%-53.20%
Enterprise Value
10,4969,1013,9653,5353,2161,359
Last Close Price
198.52182.6484.6179.5977.1337.78

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.3914.4210.6313.9266.94-
PB Ratio
124.63104.2871.9219.7230.5791.10
P/TBV Ratio
306.71257.66-29.9784.6191.10

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
13.2714.2510.2813.0664.28-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.702.473.380.980.863.18
Net Debt / Equity Ratio
-1.14-1.19-2.15-1.05-0.97-2.35
Net Debt / EBITDA Ratio
0.550.650.501.140.620.30
Net Debt / FCF Ratio
1.321.120.951.370.910.34
Asset Turnover
1.111.010.670.590.24-
Inventory Turnover
1.872.172.162.68--
Quick Ratio
1.301.451.993.462.473.75
Current Ratio
1.431.562.113.632.543.75
Return on Equity (ROE)
-245.10%-252.12%-231.63%-159.21%-298.97%-201.51%
Return on Assets (ROA)
-16.31%-16.81%-27.28%-24.86%-52.30%-56.91%
Return on Capital Employed (ROCE)
-60.70%-54.40%-74.60%-40.70%-74.70%-192.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.84%-1.99%-7.00%-6.35%-5.59%-9.16%
FCF Yield
-0.69%-1.02%-3.14%-3.87%-3.50%-7.62%
Buyback Yield / Dilution
-4.44%-3.82%-5.48%-11.73%-8.07%-1.11%
SEC Filings: 10-K · 10-Q